|
METT5D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.919350E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.513000E-01 |
| Normal-vs-Stage2 |
5.048400E-01 |
| Normal-vs-Stage3 |
9.647200E-01 |
| Normal-vs-Stage4 |
9.915600E-01 |
| Stage1-vs-Stage2 |
8.983000E-01 |
| Stage1-vs-Stage3 |
5.626200E-01 |
| Stage1-vs-Stage4 |
6.848000E-01 |
| Stage2-vs-Stage3 |
6.163400E-01 |
| Stage2-vs-Stage4 |
6.622000E-01 |
| Stage3-vs-Stage4 |
9.851200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.890600E-01 |
| Normal-vs-AfricanAmerican |
5.036400E-01 |
| Normal-vs-Asian |
3.900800E-01 |
| Caucasian-vs-AfricanAmerican |
9.588000E-01 |
| Caucasian-vs-Asian |
4.506200E-01 |
| AfricanAmerican-vs-Asian |
4.616600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.491400E-01 |
| Normal-vs-Female |
3.087000E-01 |
| Male-vs-Female |
8.143200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.010400E-01 |
| Normal-vs-Extreme_Weight |
8.523000E-01 |
| Normal-vs-Obese |
1.512190E-01 |
| Normal-vs-Extreme_Obese |
4.096400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.712200E-01 |
| Normal_Weight-vs-Obese |
7.189900E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.640000E-01 |
| Extreme_Weight-vs-Obese |
2.441400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.206600E-01 |
| Obese-vs-Extreme_Obese |
7.104400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.202000E-03 |
| Normal-vs-Age(41-60Yrs) |
9.067600E-02 |
| Normal-vs-Age(61-80Yrs) |
7.371200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.334600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.176750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.185800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.498900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.039400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.545150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.931600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.004900E-03 |
| Normal-VS-Type2 PRCC |
2.294800E-01 |
| Normal-VS-KIRP CIMP |
1.332970E-01 |
| Normal-VS-Unclassified PRCC |
5.447200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.970300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.149000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.414800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.441600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.789800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.834200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.911800E-01 |
| Normal-vs-N1 |
2.992800E-01 |
| Normal-vs-N2 |
2.907800E-02 |
| N0-vs-N1 |
1.997770E-01 |
| N0-vs-N2 |
4.442000E-01 |
| N1-vs-N2 |
2.098400E-01 |
|
|
